Authors: Yang Yuli, Luo Qingli, Lyu Hongbin DOI: 10.3760/cma.j.issn.2095-0160.2015.11.004 Published 2015-11-10 Cite as Chin J Exp Ophthalmol, 2015,33(11): 974-980. Abstract [Download PDF] [Read Full Text] Background Thyroid-associated ophthalmopathy (TAO) is a kind of clinically common and incurable ocular disease, and its incidence […]
Tag: Graves disease
The importance of basic research and drug development for thyroid-associated ophthalmopathy
Author: Fan Xianqun DOI: 10.3760/cma.j.cn115989-20200812-00582 Published 2020-11-10 Cite as Chin J Exp Ophthalmol, 2020,38(11): 905-909. Abstract [View PDF] [Read Full Text] Thyroid-associated ophthalmopathy (TAO) is an organ specific autoimmune disease with complex pathogenesis.In recent years, great progress has been made in the pathogenesis of TAO […]
Research progress in the mechanism of selenium supplement therapy for thyroid associated ophthalmopathy
Authors: Chai Peiwei, Zhou Huifang, Fan Xianqun DOI: 10.3760/cma.j.issn.2095-0160.2017.09.018 Published 2017-09-10 Cite as Chin J Exp Ophthalmol, 2017,35(9): 857-861. Abstract [Download PDF] [Read Full Text] Thyroid associated ophthalmopathy (TAO) is an organ-specific autoimmune-inflammatory disorder, ranking top among the orbital diseases with highest incidences.TAO is […]